Best Available Therapy for AIDS-Associated Kaposi Sarcoma Is Cost Effective in Africa
New research indicates that the best available chemotherapy for Kaposi sarcoma, which is infrequently used in Africa, would improve clinical outcomes and be cost-effective at its current price compared with therapies most frequently provided in the region.